摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4-fluorophenyl)-6-hydroxypyridazin-3(2H)-one

中文名称
——
中文别名
——
英文名称
2-(4-fluorophenyl)-6-hydroxypyridazin-3(2H)-one
英文别名
Pyridazine-3,6(1H,2H)-dione, 1-(4-fluorophenyl)-;2-(4-fluorophenyl)-1H-pyridazine-3,6-dione
2-(4-fluorophenyl)-6-hydroxypyridazin-3(2H)-one化学式
CAS
——
化学式
C10H7FN2O2
mdl
——
分子量
206.176
InChiKey
GMLMJTKCSBBIDL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    49.4
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    2-(4-fluorophenyl)-6-hydroxypyridazin-3(2H)-onepotassium carbonate 作用下, 以 丙酮乙腈 为溶剂, 反应 10.0h, 生成 6-(3-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)propoxy)-2-(4-fluorophenyl)pyridazin-3(2H)-one
    参考文献:
    名称:
    一种苯基哒嗪酮类衍生物的合成及其应用
    摘要:
    本发明涉及医药领域,具体地,本发明涉及具体涉及一种苯基哒嗪类衍生物及其应用。具体地,本发明涉及苯基哒嗪酮类衍生物、包含该苯基哒嗪酮类衍生物的药物组合物以及该组合物和该哒嗪酮类衍生物在制备预防或治疗精神神经疾病中的用途。哒嗪酮类衍生物具有式(I)结构。经实验发现,该类化合物可用于预防或精神神经类疾病。
    公开号:
    CN107793362B
  • 作为产物:
    描述:
    马来酸酐4-氟苯肼盐酸盐盐酸 作用下, 以 为溶剂, 反应 9.0h, 生成 2-(4-fluorophenyl)-6-hydroxypyridazin-3(2H)-one
    参考文献:
    名称:
    Expedient synthesis of new cinnoline diones by Ru-catalyzed regioselective unexpected deoxygenation-oxidative annulation of propargyl alcohols with phthalazinones and pyridazinones
    摘要:
    钌催化的简单、级联和一锅法合成了咖啉并环化二酮,通过对邻苯二酮/吡啶并咪唑酮的C-H活化。
    DOI:
    10.1039/c5cc09347c
点击查看最新优质反应信息

文献信息

  • Expedient synthesis of new cinnoline diones by Ru-catalyzed regioselective unexpected deoxygenation-oxidative annulation of propargyl alcohols with phthalazinones and pyridazinones
    作者:Subramani Rajkumar、S. Antony Savarimuthu、Rajendran Senthil Kumaran、C. M. Nagaraja、Thirumanavelan Gandhi
    DOI:10.1039/c5cc09347c
    日期:——

    Ruthenium-catalyzed simple, cascade and one-pot synthesis of cinnoline-fused diones has been carried out by the C–H activation of phthalazinones/pyridazinones.

    钌催化的简单、级联和一锅法合成了咖啉并环化二酮,通过对邻苯二酮/吡啶并咪唑酮的C-H活化。
  • Synthesis and Biological Evaluation of Novel σ<sub>1</sub> Receptor Ligands for Treating Neuropathic Pain: 6-Hydroxypyridazinones
    作者:Xudong Cao、Yin Chen、Yifang Zhang、Yu Lan、Juecheng Zhang、Xiangqing Xu、Yinli Qiu、Song Zhao、Xin Liu、Bi-Feng Liu、Guisen Zhang
    DOI:10.1021/acs.jmedchem.5b01416
    日期:2016.4.14
    framework, a new series of potent σ1 receptor ligands associated with pharmacological antineuropathic pain activity was synthesized and is described in this article. In vitro receptor binding studies revealed high σ1 receptor affinity (Ki σ1 = 1.4 nM) and excellent selectivity over not only σ2 receptor (1366-fold) but also other CNS targets (adrenergic, μ-opioid, sertonerigic receptors, etc.) for 2-(3,4-d
    通过使用6- hydroxypyridazinone框架,一个新的系列有效的σ的1具有药理antineuropathic疼痛活性相关的受体的配体合成并在本文中被描述。在体外受体结合研究显示高σ 1个受体亲和力(ķ我σ 1 = 1.4纳米)和优良的选择性超过不仅σ 2受体(1366倍),但也其他CNS目标(肾上腺素,μ阿片,sertonerigic受体等-)表示2-(3,4-二氯苯基)-6-(3-(哌啶-1-基)丙氧基)哒嗪-3(2 H)-1 (化合物54)。化合物54在小鼠福尔马林模型和大鼠慢性压迫性神经损伤疼痛(CCI)模型中显示出剂量依赖性的抗痛觉过敏特性。此外,化合物的功能活性54使用苯妥英进行了评价,表明化合物为σ 1受体拮抗剂。此外,在抗痛觉过敏剂量的轮状试验中未发现运动障碍,在运动活动试验中未见镇静副作用。最后但并非最不重要的一点是,还指出了良好的安全性和良好的药代动力学特性。
  • Direct synthesis of indazole derivatives <i>via</i> Rh(<scp>iii</scp>)-catalyzed C–H activation of phthalazinones and allenes
    作者:Chuanliu Yin、Tianshuo Zhong、Xiangyun Zheng、Lianghao Li、Jian Zhou、Chuanming Yu
    DOI:10.1039/d1ob01458g
    日期:——
    A novel Rh(III)-catalyzed annulation of phthalazinones or pyridazinones with various allenes was developed, leading to the formation of indazole derivatives bearing a quaternary carbon in moderate to good yields. The targeted products were synthesized via sequential C–H activation and olefin insertion, followed by β-hydride elimination and intramolecular cyclization. The synthetic protocol proceeded
    开发了一种新型 Rh( III ) 催化的酞嗪酮或哒嗪酮与各种丙二烯的环化反应,从而以中等至良好的产率形成带有季碳的吲唑衍生物。目标产物通过连续的C-H活化和烯烃插入,然后是β-氢化物消除和分子内环化来合成。合成方案有效地进行,具有广泛的官能团耐受性、高原子效率和高Z选择性。通过合成转化证明了该方法的实用性。
  • A ruthenium-catalyzed alkenylation–annulation approach for the synthesis of indazole derivatives <i>via</i> C–H bond activation
    作者:Maral Gholamhosseyni、Ebrahim Kianmehr
    DOI:10.1039/c8ob00999f
    日期:——
    derivatives of pyridazino[1,2-a]indazoles and indazolo[1,2-b]phthalazines were readily prepared in moderate to high yields by this methodology from easily accessible starting materials via cascade directed C–H bond activation/annulation reactions.
    N-芳基哒嗪二酮和N-芳基酞嗪二酮用丙烯酸酯进行钌催化的氧化烯基化反应,随后将所得产物在水中作为绿色溶剂进行分子内环化。吡嗪并[1,2- a ]吲唑和吲唑并[1,2- b ]酞嗪的各种衍生物可通过这种方法从中易得的起始原料通过级联定向的C–H键活化/环化反应容易地以中等至高收率制备。
  • Synthesis and biological evaluation of new 6-hydroxypyridazinone benzisoxazoles: Potential multi-receptor-targeting atypical antipsychotics
    作者:Xudong Cao、Yin Chen、Yifang Zhang、Yinli Qiu、Minquan Yu、Xiangqing Xu、Xin Liu、Bi-Feng Liu、Guisen Zhang
    DOI:10.1016/j.ejmech.2016.09.008
    日期:2016.11
    In recent years, multi-targeting directed ligands have attracted great interest as possible new atypical antipsychotics. Combinations of dopamine and serotonin receptor ligands within single molecules might afford new therapeutic opportunities. Herein, we describe the synthesis of a novel series of 6-hydroxypyridazinone benzisoxazoles and their binding behaviors to different receptors in terms of atypical antipsychotic behaviors. The most potent compound (46) exhibited excellent affinities for certain receptors (D-2, K-i = 0.5 +/- 0.07 nM; 5-HT1A, K-i = 5.9 +/- 0.8 nM; 5-HT2A, K-i = 0.3 +/- 0.01 nM; 5-HT6, K-i = 0.5 +/- 0.04 nM) and combined with low affinities for the H-1, 5-HT2C, and adrenergic alpha(1) receptors. In contrast to risperidone, compound 46 exhibited a high cataleptic threshold; this may be useful in the development of a novel class of drugs treating schizophrenia. (C) 2016 Elsevier Masson SAS. All rights reserved.
查看更多